Clinical Trial Update: ICP-332 in Subjects With Non-segmental Vitiligo [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates ICP-332 is being studied for non-segmental vitiligo in Phase 2 and Phase 3 with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-segmental Vitiligo

Drugs mentioned

• ICP-332

Snippet

Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. | Conditions: Non Segmental Vitiligo | Phase 2, Phase 3 | Status: RECRUITING